AT & T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology
HOUSTON, Oct. 7 /PRNewswire/ -- AT&T* and eCardio Diagnostics, one of the leading providers of arrhythmia monitoring solutions, today announced the combination of mobile technology with cardiac care to provide leading edge monitoring solutions for heart patients. AT&T is providing eCardio with machine-to-machine (M2M)  wireless data and mobile connectivity for near real-time, remote monitoring of cardiac patients. eCardio's monitoring solution on cardiac devices allows heart patients to recover at home rather than spend additional time in the hospital.
eCardio has implemented the monitoring solution on almost 10,000 cardiac devices with plans to deploy it across thousands more over the next year. AT&T's wireless connectivity for the monitoring solution allows doctors to have critical patient information sent to them near real-time, as circumstances occur, helping them improve response times to heart issues. Clinical productivity is improved by timely access to accurate patient information from any Internet-enabled computer. Not only does the solution provide a better patient experience, it can also help hospitals, health insurance companies, pharmacies, drug retailers and research organizations lower their costs of treating arrhythmia patients.
eCardio offers an array of clinical services and leading-edge devices designed to simplify and streamline the process of arrhythmia monitoring. This allows physicians to make more precise diagnoses and enhance the follow-up and management of their patients. eCardio has served thousands of patients suffering from heart rhythm disorders and provided physicians with leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy in the diagnoses of cardiac arrhythmias.
"We're focused on providing a total solution to physicians and patients. AT&T is helping us implement innovative